Korea Investment Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.1M Buy
110,855
+5,096
+5% +$1.66M 0.08% 240
2025
Q1
$28.6M Buy
105,759
+12,156
+13% +$3.28M 0.07% 276
2024
Q4
$22M Sell
93,603
-14,290
-13% -$3.36M 0.05% 332
2024
Q3
$29.7M Sell
107,893
-4,490
-4% -$1.23M 0.07% 274
2024
Q2
$27.3M Buy
112,383
+73,220
+187% +$17.8M 0.07% 268
2024
Q1
$5.85M Buy
39,163
+6,067
+18% +$907K 0.01% 552
2023
Q4
$6.33M Buy
33,096
+35
+0.1% +$6.7K 0.02% 536
2023
Q3
$5.86M Sell
33,061
-5,854
-15% -$1.04M 0.02% 481
2023
Q2
$7.39M Buy
38,915
+1,656
+4% +$315K 0.02% 441
2023
Q1
$7.46M Buy
37,259
+1,116
+3% +$224K 0.02% 458
2022
Q4
$8.59M Sell
36,143
-20,987
-37% -$4.99M 0.03% 455
2022
Q3
$11.4M Buy
57,130
+1,921
+3% +$385K 0.04% 397
2022
Q2
$8.05M Sell
55,209
-6,414
-10% -$935K 0.02% 468
2022
Q1
$10.1M Sell
61,623
-1,439
-2% -$235K 0.02% 442
2021
Q4
$10.7M Buy
63,062
+39,762
+171% +$6.74M 0.03% 381
2021
Q3
$4.4M Sell
23,300
-1,100
-5% -$208K 0.01% 537
2021
Q2
$4.14M Sell
24,400
-200
-0.8% -$33.9K 0.01% 567
2021
Q1
$3.47M Sell
24,600
-8,100
-25% -$1.14M 0.01% 579
2020
Q4
$4.25M Buy
32,700
+400
+1% +$52K 0.01% 538
2020
Q3
$4.7M Buy
32,300
+2,500
+8% +$364K 0.02% 439
2020
Q2
$4.41M Buy
29,800
+2,100
+8% +$311K 0.02% 452
2020
Q1
$3.02M Buy
+27,700
New +$3.02M 0.01% 485
2018
Q3
Sell
-9,302
Closed -$916K 692
2018
Q2
$916K Hold
9,302
﹤0.01% 649
2018
Q1
$1.11M Buy
+9,302
New +$1.11M 0.01% 599